Policy Archives | Page 5 of 15

What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.

by Jen Tota McGivney

From the Editor-in-Chief

Measuring a Cancer Drug’s Effectiveness

Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

by William G. Nelson, MD, PhD

Forward Look

Here Come the Biosimilars

As patents expire on biologic drugs, cancer patients get new options.

by Stephen Ornes

Policy Matters

Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

Survivor Profile

Sharing Her Strength

Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

by Lindsey Konkel

Robotic Surgery and Cancer

Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

by Sue Rochman

Pushing Progress Forward

NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

by Kevin McLaughlin

Cancer Care Moves Forward Amid COVID-19

Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

by Kate Yandell

Using Leftover Cancer Drugs to Help Others

Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.

by Jon Kelvey